CTLA4 |
P16410
|
cytotoxic T-lymphocyte associated protein 4
|
|
0.94 |
0.369 |
0.923 |
FOXP3 |
Q9BZS1
|
forkhead box P3
|
|
0.99 |
0.368 |
0.846 |
GCG |
P01275
|
glucagon
|
|
3.5E-02 |
0.431 |
0.885 |
GEM |
P55040
|
GTP binding protein overexpressed in skeletal muscle
|
|
1.2E-08 |
0.467 |
0.769 |
HLA-B |
P01889
|
major histocompatibility complex, class I, B
|
|
3.9E-05 |
0.379 |
0.885 |
HLA-C |
P10321
|
major histocompatibility complex, class I, C
|
|
1.6E-06 |
0.415 |
0.846 |
HLA-DOA |
P06340
|
major histocompatibility complex, class II, DO alpha
|
Immune response
|
3.0E-10 |
0.509 |
0.808 |
HLA-DQB1 |
P01920
|
major histocompatibility complex, class II, DQ beta 1
|
Immune response
|
8.9E-03 |
0.407 |
0.885 |
HLA-DRB1 |
P01911
|
major histocompatibility complex, class II, DR beta 1
|
Immune response
|
1.1E-03 |
0.333 |
0.923 |
IFNG |
P01579
|
interferon gamma
|
|
0.47 |
0.288 |
0.962 |
IL10 |
P22301
|
interleukin 10
|
|
5.9E-03 |
0.281 |
0.923 |
IL17A |
Q16552
|
interleukin 17A
|
|
4.3E-02 |
0.324 |
0.923 |
IL2RA |
P01589
|
interleukin 2 receptor subunit alpha
|
Receptor
|
5.5E-02 |
0.389 |
0.885 |
IL6 |
P05231
|
interleukin 6
|
|
0.32 |
0.248 |
0.962 |
INS |
P01308
|
insulin
|
|
0.30 |
0.445 |
0.923 |
ISG20 |
Q96AZ6
|
interferon stimulated exonuclease gene 20
|
|
2.9E-03 |
0.414 |
0.846 |
KIR3DL1 |
P43629
|
killer cell immunoglobulin like receptor, three Ig domains and long cytoplasmic tail 1
|
Receptor
|
8.4E-14 |
0.475 |
0.769 |
PTPN22 |
Q9Y2R2
|
protein tyrosine phosphatase non-receptor type 22
|
|
3.5E-21 |
0.438 |
0.846 |
RBM45 |
Q8IUH3
|
RNA binding motif protein 45
|
|
2.1E-10 |
0.383 |
0.846 |
RORC |
P51449
|
RAR related orphan receptor C
|
Nuclear receptor
|
1.00 |
0.576 |
0.769 |
TBX21 |
Q9UL17
|
T-box transcription factor 21
|
Transcription factor
|
1.00 |
0.541 |
0.808 |
TNF |
P01375
|
tumor necrosis factor
|
Signaling
|
0.80 |
0.231 |
0.962 |
VDR |
P11473
|
vitamin D receptor
|
Nuclear receptor
|
1.7E-05 |
0.352 |
0.885 |
WDR11 |
Q9BZH6
|
WD repeat domain 11
|
|
1.4E-08 |
0.524 |
0.808 |